[
  {
    "question": "What prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients?",
    "answer": "The excerpt indicates that the prognostic factors analyzed include the number of positive nodes and HER-2/neu status. Specifically, the paper states: 'number of positive nodes 0. 0001 0. 0002' and 'her - 2 / neu 0. 0011 < 0. 0001'. This demonstrates that both factors are statistically significant in predicting survival outcomes.",
    "source": "'number of positive nodes 0. 0001 0. 0002 her - 2 / neu 0. 0011 < 0. 0001'",
    "full_context": "[Chunk 23] univariate and multivariate analyses comparing disease - free survival ( relapse ) and overall survival to prognostic factors in node - positive patients. factor univariate ( p ) multivariate * survival relapse survival relapse number of positive nodes 0. 0001 0. 0002 0. 0003 ( 0. 0938 \u00b1 0. 0256 ) 0. 001 ( 0. 0849 \u00b1 0. 0266 ) her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 ) log ( pgr ) 0. 05 0. 05 tumor size",
    "difficulty": "hard",
    "confidence": "medium",
    "llm_type": "gpt-4o-mini",
    "timestamp": "2025-05-07 00:17:30"
  },
  {
    "question": "What potential therapeutic implications are suggested by the identification of the ligand in breast cancer?",
    "answer": "The identification of its ligand and the development of specific antagonists could have important therapeutic implications. Specifically, the paper states: 'identification of its ligand and development of specific antagonists could have important therapeutic implications.' This demonstrates that targeting the ligand may lead to new treatment strategies for breast cancer.",
    "source": "identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "full_context": "[Chunk 36] of breast cancer, identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "difficulty": "hard",
    "confidence": "high",
    "llm_type": "gpt-4o-mini",
    "timestamp": "2025-05-07 00:17:30"
  },
  {
    "question": "What is the significance of the her-2/neu oncogene in human breast cancer as discussed in the excerpt?",
    "answer": "The her-2/neu oncogene is significant in human breast cancer as it has been shown to be amplified in breast cancer cell lines. Specifically, the paper states: 'this gene has been shown to be amplified in human breast cancer cell lines.' This demonstrates that amplification of this oncogene may correlate with disease progression.",
    "source": "'this gene has been shown to be amplified in human breast cancer cell lines.'",
    "full_context": "[Chunk 0] human breast cancer : correlation of relapse and survival with amplification of the her - 2 / neu oncogene authors : dennis j. slamon, gary m. clark, steven g. wong, wendy j. levin, axel ullrich, william l. mcguire abstract the her - 2 / neu oncogene is a member of the erbb - like oncogene family, and is related to, but distinct from, the epidermal growth factor receptor. this gene has been shown to be amplified in human breast cancer cell lines. in the current study, alterations of the gene in 189 primary human breast cancers were investigated. her - 2 / neu was found to be amplified from 2 -",
    "difficulty": "easy",
    "confidence": "high",
    "llm_type": "gpt-4o-mini",
    "timestamp": "2025-05-07 00:17:30"
  },
  {
    "question": "What method was used to analyze alterations in the her - 2 / neu gene in the study?",
    "answer": "The study utilized Southern blot analysis to evaluate alterations in the her - 2 / neu gene. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.' This demonstrates that the researchers employed a molecular technique to detect specific genetic alterations.",
    "source": "'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.'",
    "full_context": "[Chunk 10] evaluated for alterations in the her - 2 / neu gene. dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna. results analysis of her - 2 / neu gene amplification figure 1 description : figure 1 shows the analysis of alterations of the her - 2 / neu gene in human breast cancer. the image displays southern blot analysis of 79 of the 189 breast tumors used in this study. tumors were categorized based on their her - 2 / neu copy number : - single copy of her - 2 / neu :",
    "difficulty": "easy",
    "confidence": "high",
    "llm_type": "gpt-4o-mini",
    "timestamp": "2025-05-07 00:17:30"
  },
  {
    "question": "What specific technique and probe were used to evaluate alterations in the HER-2/neu gene in breast cancer tumors?",
    "answer": "According to the excerpt, Southern blot analysis with a 32P-labeled HER-2/neu-1 probe was used to evaluate alterations in the HER-2/neu gene in breast cancer tumors. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.' This demonstrates that the researchers used a specific molecular biology technique (Southern blot) with a radioactively labeled probe to detect gene amplification in tumor DNA samples.",
    "source": "dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.",
    "full_context": "[Chunk 10] evaluated for alterations in the her - 2 / neu gene. dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna. results analysis of her - 2 / neu gene amplification figure 1 description : figure 1 shows the analysis of alterations of the her - 2 / neu gene in human breast cancer. the image displays southern blot analysis of 79 of the 189 breast tumors used in this study. tumors were categorized based on their her - 2 / neu copy number : - single copy of her - 2 / neu :",
    "difficulty": "medium",
    "confidence": "high",
    "llm_type": "claude-3-5-sonnet-20240620",
    "timestamp": "2025-05-07 00:17:31"
  },
  {
    "question": "What was observed regarding the HER-2/neu loci in the study?",
    "answer": "The study observed that in two of the three cases, the rearrangement of the HER-2/neu loci was identical, and additionally, two of the rearranged HER-2/neu loci were amplified. Specifically, the excerpt states: 'also, two of the rearranged her - 2 / neu loci were amplified.' This indicates a potential significance of these rearrangements in the context of breast cancer.",
    "source": "'also, two of the rearranged her - 2 / neu loci were amplified.'",
    "full_context": "[Chunk 28] and in two of the three cases, the rearrangement was identical. also, two of the rearranged her - 2 / neu loci were amplified. the incidence of her - 2 / neu rearrangement as determined by eco ri digestion was too small to attempt statistical correlations. figure 4 description : figure 4 shows an example of rehybridization of filter with human egfr probe. the image displays the lower molecular weight bands hybridized with 32 p - labeled egfr probe from tumor samples. the bands from top to bottom are 2. 8, 2. 2, and 1. 8 kb, respectively. lane 52 is highlighted as an example of a tumor showing marked amplification ( > 50",
    "difficulty": "medium",
    "confidence": "medium",
    "llm_type": "claude-3-5-sonnet-20240620",
    "timestamp": "2025-05-07 00:17:31"
  },
  {
    "question": "How do the proteins produced by the HER-2/neu and EGFR genes differ in size?",
    "answer": "According to the excerpt, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR gene. Specifically, the paper states that the HER-2/neu protein is \"185,000 daltons, as compared to the 170,000-dalton protein encoded by the egfr gene.\"",
    "source": "finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene.",
    "full_context": "[Chunk 7] 13 of chromosome 7, where the egfr gene is located. also, the her - 2 / neu gene generates a messenger rna ( mrna ) of 4. 8 kb, which differs from the 5. 8 - and 10 - kb transcripts for the egfr gene. finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene. conversely, on the basis of sequence data, her - 2 / neu is more closely related to the egfr gene than to other members of the tyrosine kinase family. like the egfr protein, her - 2 / neu has an extra",
    "difficulty": "easy",
    "confidence": "high",
    "llm_type": "gemini-2.5-flash-preview-04-17",
    "timestamp": "2025-05-07 00:17:31"
  },
  {
    "question": "What impact does HER-2/neu amplification have on overall survival and relapse in node-positive breast cancer patients according to the excerpt?",
    "answer": "The excerpt indicates that patients with HER-2/neu amplification have significantly different outcomes compared to those without amplification. Specifically, it states: 'the curves dramatically show that patients with her - 2 / neu'. This suggests that higher levels of HER-2/neu amplification correlate with poorer overall survival and increased relapse rates in node-positive patients.",
    "source": "'the curves dramatically show that patients with her - 2 / neu'",
    "full_context": "[Chunk 25] ##lification ( > 2 copies ) of her - 2 / neu - figure 3 b : actuarial curve for overall survival in node - positive patients with no amplification versus node - positive patients with any amplification ( > 2 copies ) of her - 2 / neu - figure 3 c : actuarial curve for relapse in node - positive patients with no amplification versus node - positive patients with greater than 5 copies of her - 2 / neu - figure 3 d : actuarial curve for overall survival in node - positive patients with no amplification versus node - positive patients with greater than 5 copies of her - 2 / neu the curves dramatically show that patients with her - 2 / neu",
    "difficulty": "easy",
    "confidence": "medium",
    "llm_type": "gemini-2.5-flash-preview-04-17",
    "timestamp": "2025-05-07 00:17:31"
  },
  {
    "question": "What impact does HER-2/neu gene amplification have on patient outcomes according to the excerpt?",
    "answer": "The excerpt indicates that patients with HER-2/neu gene amplification, particularly those with more than 5 copies, had significantly worse outcomes. Specifically, it states: 'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'. This demonstrates that higher levels of gene amplification correlate with poorer survival rates.",
    "source": "'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'",
    "full_context": "[Chunk 26] / neu amplification, particularly those with > 5 copies, had significantly worse outcomes in terms of both disease - free survival and overall survival. while there was a somewhat shortened time to relapse and shorter overall survival in patients having any amplification of the her - 2 / neu gene in their tumors ( fig. 3, a and b ), the greatest differences were found when comparing patients with > 5 copies of the gene to those without amplification ( single copy ) ( fig. 3, c and d ). patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times ( p = 0. 015 ) and overall survival times ( p = 0. 06 ) when",
    "difficulty": "medium",
    "confidence": "high",
    "llm_type": "gpt-4o-mini",
    "timestamp": "2025-05-07 00:17:31"
  },
  {
    "question": "What types of evidence support the link between proto-oncogenes and human malignancies according to the excerpt?",
    "answer": "The excerpt outlines several types of evidence that support the link between proto-oncogenes and human malignancies. It states that this evidence is derived from 'studies of animal models, tumor cell lines, and actual human tumors.' Additionally, it mentions specific data including 'sequence homology between human proto-oncogenes and the viral oncogenes of transforming retroviruses,' 'transfection studies showing the transforming potential of proto-oncogenes in nih 3 t 3 cells and primary embryo fibroblasts,' and 'the central role of certain proto-oncogenes in tumorigen.' This demonstrates that the relationship is supported by both experimental and comparative studies.",
    "source": "'the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors.'",
    "full_context": "[Chunk 2] introduction the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors. data from animal models and cell lines include : 1. sequence homology between human proto - oncogenes and the viral oncogenes of transforming retroviruses that are known to be tumorigenic in some species 2. transfection studies showing the transforming potential of proto - oncogenes in nih 3 t 3 cells and primary embryo fibroblasts 3. the central role of certain proto - oncogenes in tumorigen",
    "difficulty": "medium",
    "confidence": "medium",
    "llm_type": "gpt-4o-mini",
    "timestamp": "2025-05-07 00:17:31"
  },
  {
    "question": "How does HER-2/neu gene amplification impact prognosis in breast cancer patients, and how does its prognostic value compare to other factors?",
    "answer": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in breast cancer patients. The study found that it retained its significance even when adjusted for other known prognostic factors. Notably, HER-2/neu amplification showed greater prognostic value than most currently used factors, including hormonal-receptor status, particularly in lymph node-positive disease. This suggests that the HER-2/neu gene may play a crucial role in the biological behavior and/or pathogenesis of human breast cancer.",
    "source": "amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer.",
    "full_context": "[Chunk 1] from 2 - to greater than 20 - fold in 30 % of the tumors. correlation of gene amplification with several disease parameters was evaluated. amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer. introduction the evidence",
    "difficulty": "easy",
    "confidence": "high",
    "llm_type": "claude-3-5-sonnet-20240620",
    "timestamp": "2025-05-07 00:17:32"
  },
  {
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor for patients with node-positive breast cancer. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant in predicting disease behavior, even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account'",
    "full_context": "[Chunk 27] 06 ) when compared to patients with no amplification. to determine if amplification of her - 2 / neu was independent of other known prognostic factors in predicting disease behavior, multivariate survival analyses were performed on the 86 node - positive cases. amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account ( table 4 ). gene rearrangement and comparison with egfr rearrangement of the her - 2 / neu gene was rare. of the total 189 tumors evaluated, three showed evidence of rearrangement, and in two",
    "difficulty": "easy",
    "confidence": "high",
    "llm_type": "claude-3-5-sonnet-20240620",
    "timestamp": "2025-05-07 00:17:32"
  },
  {
    "question": "What is the statistical significance of HER-2/neu as a prognostic factor for relapse in node-positive breast cancer patients according to the multivariate analysis?",
    "answer": "According to the multivariate analysis presented in the excerpt, HER-2/neu is a statistically significant prognostic factor for relapse in node-positive breast cancer patients. Specifically, the paper states that HER-2/neu has a p-value of '0.001 (0.1378 \u00b1 0.0425)' for relapse in the multivariate analysis. This demonstrates that HER-2/neu is a strong predictor of disease recurrence, with a highly significant p-value of 0.001.",
    "source": "her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 )",
    "full_context": "[Chunk 23] univariate and multivariate analyses comparing disease - free survival ( relapse ) and overall survival to prognostic factors in node - positive patients. factor univariate ( p ) multivariate * survival relapse survival relapse number of positive nodes 0. 0001 0. 0002 0. 0003 ( 0. 0938 \u00b1 0. 0256 ) 0. 001 ( 0. 0849 \u00b1 0. 0266 ) her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 ) log ( pgr ) 0. 05 0. 05 tumor size",
    "difficulty": "hard",
    "confidence": "medium",
    "llm_type": "claude-3-5-sonnet-20240620",
    "timestamp": "2025-05-07 00:17:32"
  },
  {
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor in node-positive breast cancer patients. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients'",
    "full_context": "[Chunk 27] 06 ) when compared to patients with no amplification. to determine if amplification of her - 2 / neu was independent of other known prognostic factors in predicting disease behavior, multivariate survival analyses were performed on the 86 node - positive cases. amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account ( table 4 ). gene rearrangement and comparison with egfr rearrangement of the her - 2 / neu gene was rare. of the total 189 tumors evaluated, three showed evidence of rearrangement, and in two",
    "difficulty": "hard",
    "confidence": "high",
    "llm_type": "claude-3-5-sonnet-20240620",
    "timestamp": "2025-05-07 00:17:32"
  },
  {
    "question": "Based on the comparison of amplification levels for two related tyrosine kinase receptors in human breast cancer, what conclusion does the excerpt draw regarding the generality of gene amplification as a phenomenon in this specific malignancy?",
    "answer": "The excerpt concludes that the significant difference in amplification levels between the two related tyrosine kinase receptors suggests that gene amplification is not a universally applicable phenomenon for this class of receptors in human breast cancer. Specifically, the paper states: \"of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.\"",
    "source": "of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.",
    "full_context": "[Chunk 30] of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer. discussion the exact role of various proto - oncogenes in the pathogenesis of human malignancies remains unclear. one line of evidence implicating abnormalities of these genes in human disease is association of their amplification with tumor progression in specific cancers. the n - myc gene is frequently amplified in human neuroblastomas and neuroblastoma cell lines. studies on the n - myc proto - oncogene were the first to show a direct association between abnormalities in a proto - oncogen",
    "difficulty": "medium",
    "confidence": "high",
    "llm_type": "gemini-2.5-flash-preview-04-17",
    "timestamp": "2025-05-07 00:17:34"
  },
  {
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "full_context": "[Chunk 24] 05 tumor size 0. 06 0. 06 log ( er ) 0. 15 0. 10 0. 03 ( - 0. 5158 \u00b1 0. 2414 ) age 0. 22 0. 61 cox ' s partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. results are shown as p ( regression coefficient \u00b1 se ). figure 3 description : figure 3 shows actuarial survival curves demonstrating the relationship between her - 2 / neu amplification and patient outcomes : - figure 3 a : actuarial curve for relapse in node - positive patients with no amplification versus node - positive patients with any amplification (",
    "difficulty": "medium",
    "confidence": "high",
    "llm_type": "gemini-2.5-flash-preview-04-17",
    "timestamp": "2025-05-07 00:17:34"
  },
  {
    "question": "Based on the structural description provided in the excerpt for the protein identified as \"[Chunk 8]\", what specific features lead to the inference that it is likely a cellular receptor?",
    "answer": "According to the excerpt, the inference that the protein \"[Chunk 8]\" is likely a cellular receptor is based on its specific domain structure. The text states: \"[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.\" These distinct domains, particularly the extracellular and transmembrane components, are characteristic of receptor proteins.",
    "source": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.",
    "full_context": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand. study design and methods as a result of the published data showing amplification of her - 2 / neu in a human mammary carcinoma cell line, and as part of an ongoing survey in our laboratory of proto - oncogene abnormalities in human tumors, we evaluated alterations of the her - 2 / neu gene in a large series of human primary breast cancers. factors that are known to be important in the prognosis of breast malignancies in individual patients include : size of",
    "difficulty": "hard",
    "confidence": "high",
    "llm_type": "gemini-2.5-flash-preview-04-17",
    "timestamp": "2025-05-07 00:17:34"
  },
  {
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "full_context": "[Chunk 24] 05 tumor size 0. 06 0. 06 log ( er ) 0. 15 0. 10 0. 03 ( - 0. 5158 \u00b1 0. 2414 ) age 0. 22 0. 61 cox ' s partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. results are shown as p ( regression coefficient \u00b1 se ). figure 3 description : figure 3 shows actuarial survival curves demonstrating the relationship between her - 2 / neu amplification and patient outcomes : - figure 3 a : actuarial curve for relapse in node - positive patients with no amplification versus node - positive patients with any amplification (",
    "difficulty": "hard",
    "confidence": "high",
    "llm_type": "gemini-2.5-flash-preview-04-17",
    "timestamp": "2025-05-07 00:17:34"
  }
]